IDEAYA Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-4.1M | $9.7M |
| FY2017 | — | $-15.7M | $6.0M |
| FY2018 | — | $-48.9M | $20.5M |
| FY2019 | — | $100.4M | $34.1M |
| FY2020 | — | $198.3M | $72.0M |
| FY2021 | — | $301.5M | $92.0M |
| FY2022 | — | $349.5M | $68.6M |
| FY2023 | — | $621.1M | $157.0M |
| FY2024 | — | $1.06B | $84.4M |
| FY2025 | — | $1.02B | $112.8M |